Index Entries - Covid Index

1536 Results

Title	IS Publication Date
Potential adverse effects of nanoparticles on the reproductive system	December 11, 2018
Potential adverse events in Japanese women who received tozinameran (BNT162b2, Pfizer-BioNTech)	May 31, 2021
Potential Clinical Benefits of Quercetin in the Early Stage of COVID-19: Results of a Second, Pilot, Randomized, Controlled and Open-Label Clinical Trial	June 24, 2021
Potential Conscientious Objection to mRNA Technology as Preventive Treatment for COVID-19	August 23, 2022
Potential health risks of mRNA-based vaccine therapy: A hypothesis	January 25, 2023
Potential Links Between the Wuhan Institute of Virology and the Origin of the COVID-19 Pandemic	June 2023
Pre-infection 25-hydroxyvitamin D3 levels and association with severity of COVID-19 illness	February 3, 2022
Predominance of antibody-resistant SARS-CoV-2 variants in vaccine breakthrough cases from the San Francisco Bay Area, California	January 10, 2022
Preexisting and de novo humoral immunity to SARS-CoV-2 in humans	December 11, 2020
Pregnancy-Related Deaths in the US, 2018-2022	April 9, 2025
Preliminary Evidence of a Link between COVID-19 Vaccines and Otologic Symptoms	February 24, 2022
Preliminary Findings of a Randomized Trial of Non-Pharmaceutical Interventions to Prevent Influenza Transmission in Households	May 7, 2008
Premenstrual and menstrual changes reported after COVID-19 vaccination: The EVA project	July 14, 2022
Prenatal Exposure to COVID-19 mRNA Vaccine BNT162b2 Induces Autism-Like Behaviors in Male Neonatal Rats: Insights into WNT and BDNF Signaling Perturbations	January 10, 2024
PREP Act 5th Amendment	January 28, 2021
Preparedness for a High-Impact Respiratory Pathogen Pandemic	September 18, 2019
Presence of viral spike protein and vaccinal spike protein in the blood serum of patients with long-COVID syndrome	December 27, 2023
President of Bayer's Pharmaceutical Division — mRNA vaccines are a gene therapy — World Health Summit 2021	October 24, 2021
Press Briefing by White House COVID-19 Response Team and Public Health Officials	December 29, 2021
Press Release: Independent Pharmacovigilance Report Confirms Evidence for Recall of Covid-19 Vaccines	June 11, 2022
Press Release: UK Doctors Call For Government To Urgently Pause and Investigate the Use of Novel mRNA Covid Vaccines	December 21, 2022
Press-conference: Remarks by Florida Attorney General, Dr. Joseph A. Ladapo	October 25, 2021
Prevalence and Characteristics Associated With Post–COVID-19 Condition Among Nonhospitalized Adolescents and Young Adults	March 30, 2023
Prevalence and Mechanisms of Mucus Accumulation in COVID-19 Lung Disease	July 11, 2022
Prevalence and Risk Factors for School-Associated Transmission of SARS-CoV-2	August 4, 2023
Prevention and Treatment Protocols for COVID-19
Preventive Vitamin D Supplementation and Risk for COVID-19 Infection: A Systematic Review and Meta-Analysis	February 28, 2024
Primary exposure to SARS-CoV-2 protects against reinfection in rhesus macaques	July 2, 2020
Prion-like Domains in Spike Protein of SARS-CoV-2 Differ across Its Variants and Enable Changes in Affinity to ACE2	January 25, 2022
Probiotic improves symptomatic and viral clearance in Covid19 outpatients: a randomized, quadruple-blinded, placebo-controlled trial	January 11, 2022
Project Grant; FAIN R01AI110964	June 1, 2014
Propolis and its potential against SARS-CoV-2 infection mechanisms and COVID-19 disease: Running title: Propolis against SARS-CoV-2 infection and COVID-19	August 17, 2020
Propolis, Bee Honey, and Their Components Protect against Coronavirus Disease 2019 (COVID-19): A Review of In Silico, In Vitro, and Clinical Studies	February 25, 2021
Prospective Case-Control Study of Cardiovascular Abnormalities 6 Months Following Mild COVID-19 in Healthcare Workers	November 2021
Prospective Cohort of Fluvoxamine for Early Treatment of Coronavirus Disease 19	February 1, 2021
Protecting Youth Mental Health - The U.S. Surgeon General’s Advisory	December 2021
Protection from COVID-19 vaccination and prior SARS-CoV-2 infection among children aged 6 months – 4 years, United States, September 2022–April 2023	December 5, 2024
Protection from previous natural infection compared with mRNA vaccination against SARS-CoV-2 infection and severe COVID-19 in Qatar: a retrospective cohort study	November 11, 2022
Protracted yet Coordinated Differentiation of Long-Lived SARS-CoV-2-Specific CD8+ T Cells during Convalescence
Provisional Death Counts for Coronavirus Disease (COVID-19): Weekly Updates by Select Demographic and Geographic characteristics (May 13, 2020)	May 13, 2020
Provisional deaths and excess mortality in Canada dashboard	Last modified December 14, 2023
Proximal Origin of Epidemic Highly Pathogenic Avian Influenza H5N1 Clade 2.3.4.4b and Spread by Migratory Waterfowl	November 4, 2024
Psychiatric adverse events following COVID-19 vaccination: a population-based cohort study in Seoul, South Korea	June 4, 2024
Psychological distress associated with COVID-19 quarantine: Latent profile analysis, outcome prediction and mediation analysis	August 7, 2020
Psychological distress during the COVID-19 lockdown: The young adults most at risk	September 25, 2020
Public Health and Medical Professionals for Transparency
Public health ethics: critiques of the “new normal”	September 27, 2022
Public Health Lessons Learned From Biases in Coronavirus Mortality Overestimation	August 12, 2020
Public Health Scotland COVID-19 Statistical Report As at 01 November 2021	November 3, 2021
Public Health Scotland COVID-19 Statistical Report As at 10 January 2022	January 12, 2022

Page 21 of 31